Gentian Diagnostics AS (GENT) — Cash Flow Reinvestment Rate
Gentian Diagnostics AS (GENT) has a Cash Flow Reinvestment Rate of 0.25x as of December 2025, reinvesting Nkr10.76 Million (capex Nkr10.76 Million ) from operating cash flow of Nkr42.59 Million. Explore GENT capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gentian Diagnostics AS Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Gentian Diagnostics AS across 4 annual periods. Also explore GENT asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Gentian Diagnostics AS (2013–2025)
Year-by-year capital reinvestment analysis for Gentian Diagnostics AS. For live market cap and broader valuation context, see market cap of Gentian Diagnostics AS.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | Nkr10.76 Million | Nkr42.59 Million | Nkr10.76 Million | ▼ -84.5% |
| 2024 | 1.63x | Nkr21.90 Million | Nkr13.46 Million | Nkr10.95 Million | ▲ +147.8% |
| 2023 | 0.66x | Nkr10.15 Million | Nkr15.46 Million | Nkr4.49 Million | ▼ -54.2% |
| 2013 | 1.44x | Nkr3.49 Million | Nkr2.43 Million | Nkr3.49 Million | — |